<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="dict8/PMC7229974/results/search/disease/results.xml">
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="coronavirus, emerging towards the end of 2019 and subsequently named" exact="Severe" post="Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, the virus that"/>
  <result pre="emerging towards the end of 2019 and subsequently named Severe" exact="Acute" post="Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, the virus that causes"/>
  <result pre="towards the end of 2019 and subsequently named Severe Acute" exact="Respiratory" post="Syndrome Coronavirus 2 (SARS-CoV-2, the virus that causes Coronavirus"/>
  <result pre="the end of 2019 and subsequently named Severe Acute Respiratory" exact="Syndrome" post="Coronavirus 2 (SARS-CoV-2, the virus that causes Coronavirus Disease"/>
  <result pre="Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, the virus that causes Coronavirus" exact="Disease" post="2019 [COVID-19]) has been associated with an epidemic initially"/>
  <result pre="globalize world, it immediately became well clear that this fearsome" exact="infection" post="could not be confined to China only, but soon"/>
  <result pre="the country with the highest number of cases of SARS-CoV-2" exact="infection" post="after USA and this has generated an unprecedented health"/>
  <result pre="been investigated, with reported positive outcomes, in outbreaks of other" exact="viral" post="infections, including the 1918 Spanish H1N1 influenza A pandemic"/>
  <result pre="Spanish H1N1 influenza A pandemic and, more recently, the 2003" exact="Avian" post="H5N1 influenza A epidemic, the 2003 SARS-CoV-1 epidemic, the"/>
  <result pre="epidemic, the 2009-2010 H1N1 influenza pandemic, the 2012 Middle East" exact="Respiratory" post="Syndrome (MERS)-CoV epidemic, and the 2014 Ebola epidemic [5]."/>
  <result pre="the 2009-2010 H1N1 influenza pandemic, the 2012 Middle East Respiratory" exact="Syndrome" post="(MERS)-CoV epidemic, and the 2014 Ebola epidemic [5]. Pertaining"/>
  <result pre="epidemic, and the 2014 Ebola epidemic [5]. Pertaining to the" exact="respiratory" post="CoV infections, a number of studies have been conducted"/>
  <result pre="meta-analysis performed in 2015 identified 32 studies of SARS coronavirus" exact="infection" post="and severe influenza. These studies involved 699 treated patients"/>
  <result pre="Following transfusion, 4 out of 5 patients experienced increases in" exact="viral" post="antibody titers, decreases in SARS-CoV-2 viral loads, and normalization"/>
  <result pre="patients experienced increases in viral antibody titers, decreases in SARS-CoV-2" exact="viral" post="loads, and normalization of temperature and resolution of acute"/>
  <result pre="SARS-CoV-2 viral loads, and normalization of temperature and resolution of" exact="acute" post="respiratory distress syndrome (ARDS) [7]. Duan and colleagues presented"/>
  <result pre="viral loads, and normalization of temperature and resolution of acute" exact="respiratory" post="distress syndrome (ARDS) [7]. Duan and colleagues presented a"/>
  <result pre="and normalization of temperature and resolution of acute respiratory distress" exact="syndrome" post="(ARDS) [7]. Duan and colleagues presented a series of"/>
  <result pre="antibody (&amp;gt;1:640) at a median of 16.5 days [8]. The" exact="primary" post="endpoint was safety, which was demonstrated as all patients"/>
  <result pre="all patients tolerated plasma transfusion without severe adverse events. The" exact="secondary" post="endpoints included improvement of clinical symptoms and of laboratory"/>
  <result pre="saturation and lymphocyte count and decrease in C-reactive protein, SARS-CoV-2" exact="viral" post="load and lung lesions on radiological examination [8]. Zhang"/>
  <result pre="at a median of 21.5 days after first detection of" exact="viral" post="shedding, led to the discontinuation of the SARS-CoV-2 shedding"/>
  <result pre="able to improve the survival in these patients with advanced" exact="disease" post="(5/6 and 14/15 deaths in the convalescent plasma group"/>
  <result pre="plasma should be used in an early phase of the" exact="disease" post="to obtain the best effect [10]. Following these first"/>
  <result pre="and considering the efficacy of this treatment in previous severe" exact="viral" post="epidemics and the absence of standardized treatments, the Food"/>
  <result pre="of this treatment in previous severe viral epidemics and the" exact="absence of" post="standardized treatments, the Food and Drug Administration (FDA) approved"/>
  <result pre="plasma, including donorsâ€™ selection (i.e., age, gender, diagnosis of SARS-Cov-2" exact="infection" post="and of recovery, anti-SARS-CoV-2 antibody titer required for plasma"/>
  <result pre="collection and biologic qualification (number, volume and frequency of donations," exact="infectious disease" post="markers and pathogen inactivation) and treatment and disease characteristics"/>
  <result pre="and biologic qualification (number, volume and frequency of donations, infectious" exact="disease" post="markers and pathogen inactivation) and treatment and disease characteristics"/>
  <result pre="donations, infectious disease markers and pathogen inactivation) and treatment and" exact="disease" post="characteristics (i.e., dose and timing of convalescent plasma infused"/>
  <result pre="and timing of convalescent plasma infused and stage of the" exact="disease" post="at which to start convalescent plasma treatment). There is"/>
  <result pre="J EpidemiolFeb 222020[Epub ahead of print] 2World Health Organization. Coronavirus" exact="disease" post="(COVID-19) outbreak. https://www.who.int/emergencies/diseases/novel-coronavirus-2019[accessed 2020-5-4]. 3ZhaiP.DingY.WuX.LongJ.ZhongY.LiY.The epidemiology, diagnosis and treatment"/>
  <result pre="of print] 5WongH.K.LeeC.K.Pivotal role of convalescent plasma in managing emerging" exact="infectious" post="diseasesVox SangApr 2202010.1111/vox.12927 6Mair-JenkinsJ.Saavedra-CamposM.BaillieJ.K.Convalescent plasma study group. The effectiveness"/>
  <result pre="convalescent plasma and hyperimmune immunoglobulin for the treatment of severe" exact="acute" post="respiratory infections of viral etiology: a systematic review and"/>
  <result pre="plasma and hyperimmune immunoglobulin for the treatment of severe acute" exact="respiratory" post="infections of viral etiology: a systematic review and exploratory"/>
  <result pre="and hyperimmune immunoglobulin for the treatment of severe acute respiratory" exact="infections" post="of viral etiology: a systematic review and exploratory meta-analysisJ"/>
  <result pre="immunoglobulin for the treatment of severe acute respiratory infections of" exact="viral" post="etiology: a systematic review and exploratory meta-analysisJ Infect Dis2112015809025030060"/>
  <result pre="312020(Epub ahead of print) 10ZengQ.L.YuZ.J.GouJ.J.Effect of convalescent plasma therapy on" exact="viral" post="shedding and survival in COVID-19 patientsJ Infect DisApr 292020(Epub"/>
 </snippets>
</snippetsTree>
